Phosphatidyl-Inositol-3-Kinase Alpha Catalytic Subunit Mutation and Response to Neoadjuvant Endocrine Therapy for Estrogen Receptor Positive Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-009-0575-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Impact of Adding the Multikinase Inhibitor Sorafenib to Endocrine Therapy in Metastatic Estrogen Receptor-Positive Breast Cancer

Future Oncology
MedicineCancer ResearchOncology
2014English

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

Frontiers in Oncology
Cancer ResearchOncology
2017English

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Response to Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy

Cancer Research
Cancer ResearchOncology
2010English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Raptor Localization Predicts Prognosis and Tamoxifen Response in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy